LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • June 23rd, 2023 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Cooperation, Supply and Commercialization Agreement, executed and delivered as of June 19, 2023 (the “Execution Date”), is by and between Santhera Pharmaceuticals (Schweiz) AG and Santhera Pharmaceuticals Holding AG, both corporations organized under the laws of Switzerland and having their principal office at Hohenrainstrasse 24, 4133 Pratteln, Switzerland (collectively, “Santhera”), and Catalyst Pharmaceuticals Inc., a corporation organized under the laws of Delaware, U.S. and having its principal office at 355 Alhambra Circle, Suite 801, Coral Gables, FL 33134, U.S. (“Catalyst”). Each of Catalyst and Santhera may be referred to herein as a “Party” or collectively as the “Parties”.
ContractInvestment Agreement • June 23rd, 2023 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations
Certain identified information has been excluded from this exhibit because it is both (i) not material, and (ii) would likely cause competitive harm to the registrant if publicly disclosed. [***] indicates that information has been redacted.
